Lowest Price Guaranteed From USD 4,799
Companies Covered
71
Pages
183
View Count
8963
The 4D bioprinting market is estimated to be worth $21 million in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 34.0% during the forecast period. The concept of 3D printing has been one of the biggest revolutions across the globe. Various industry stakeholders and academicians have undertaken several initiatives to further develop / improve this technology for a variety of applications. One such application area is 3D bioprinting that includes the printing of living cells and enables the development of highly complex tissues that mimic the structure and performance ability of desired organ, within the body. Although 3D bioprinting results in the printing of an exact replica of primary human organs, however, the printed 3D objects are inert and static in nature and are unable to change shape when subjected to environmental changes. 4D bioprinting makes this possible; 4D bioprinting refers to the incorporation of a fourth dimension that enables these structures to change their shape with time. The additional element in the bioprinting technology that enables the fourth dimension, includes application of smart materials, which have the tendency to morph in the presence of stimuli (such as, heat, water, light, electricity, magnetic energy, stress, strain, and pressure). In addition to the ability to morph, these 4D printed structures have the ability to self-repair and can adapt to various environmental changes. This technology, though, is currently associated with several challenges; these include printing the existing stimuli-responsive materials and optimizing them with bio-inks. Assembling and folding deformations in 4D printed structures is also quite demanding.
Owing to the ongoing advancements in the 4D biofabrication technology, several players are actively adopting and developing 4D bioprinters and smart biomaterials. It is worth highlighting that 4D bioprinting is garnering a lot of attention from academicians and industry players. In fact, the volume of affiliated scientific literature has increased at a rate of ~130% since last five years, demonstrating the growing popularity of 4D bioprinting. Further, looking at the wide range of applications associated with the 4D bioprinting, such as tissue engineering, regenerative medicine, and drug related applications, a number of start-ups have also emerged in this domain. Given the rising interest of stakeholders towards technological advancements and growing adoption of 4D bioprinting for above mentioned applications, we believe that the overall market for 4D bioprinting is anticipated to witness substantial growth in the coming years.
![]() |
![]() |
![]() |
The 4D Bioprinting Market – Distribution by Type of Technology (Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology and Others), Application Area (Biomedical Applications and Others), End-user (Pharmaceutical and Biotechnology Companies, Academic Research and Development and Other End-users) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future potential of the 4D bioprinting market. The study features an in-depth analysis, highlighting the capabilities of 4D bioprinter and smart biomaterial developers. Amongst other elements, the report includes:
![]() |
![]() |
![]() |
One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the 4D bioprinting market, over the coming 12 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term, and long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of technology (extrusion-based technology, laser-based technology, inkjet-based technology and others), application area (biomedical applications and others), end-user (pharmaceutical and biotechnology companies, academic research and development and other end-users), key geographical regions (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals:
The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments as defined in the below table:
Report Attributes | Details | |
Forecast Period |
2023 – 2035 |
|
Type of Technology |
Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology, Other Technologies |
|
Application Area |
Biomedical Applications, Other Applications |
|
End-user |
Pharmaceutical and Biotechnology Companies, Academic Research and Development, Other End-Users | |
Key Geographical Regions |
North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa |
|
Key Companies Profiled |
DirectSync Surgical, Enovis, Ferentis, Poietis, REGENHU, ROKIT Healthcare, Sculpteo, SMART3D, Stratasys, VIVAX BIO |
|
Customization Scope | 15% Free Customization Option | |
PowerPoint Presentation (Complementary) | Available | |
Excel Data Packs (Complimentary) | 4D Bioprinters: Market Landscape Analysis, Smart Biomaterials: Market Landscape Analysis, Benchmarking Analysis, Product Competitiveness Analysis, Market Forecast and Opportunity Analysis |
![]() |
![]() |
![]() |